Insider Selling: Cigna Group (NYSE:CI) Insider Sells $496,636.29 in Stock

Cigna Group (NYSE:CI) insider Everett Neville sold 1,719 shares of the business’s stock in a transaction that occurred on Monday, March 2nd. The stock was sold at an average price of $288.91, for a total transaction of $496,636.29. Following the sale, the insider directly owned 5,670 shares in the company, valued at approximately $1,638,119.70. This represents a 23.26% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink.

Cigna Group Trading Down 1.2%

Shares of Cigna Group stock opened at $281.21 on Friday. The firm’s 50 day simple moving average is $280.80 and its two-hundred day simple moving average is $284.43. The firm has a market capitalization of $74.11 billion, a price-to-earnings ratio of 12.68, a PEG ratio of 0.99 and a beta of 0.27. Cigna Group has a 12-month low of $239.51 and a 12-month high of $350.00. The company has a current ratio of 0.74, a quick ratio of 0.74 and a debt-to-equity ratio of 0.74.

Cigna Group (NYSE:CI) last announced its quarterly earnings data on Thursday, February 5th. The health services provider reported $8.08 earnings per share for the quarter, beating analysts’ consensus estimates of $7.88 by $0.20. The firm had revenue of $72.50 billion for the quarter, compared to analyst estimates of $69.53 billion. Cigna Group had a net margin of 2.17% and a return on equity of 19.46%. The business’s quarterly revenue was up 10.4% compared to the same quarter last year. During the same period in the previous year, the company earned $6.64 earnings per share. Cigna Group has set its FY 2026 guidance at 30.250- EPS. Analysts predict that Cigna Group will post 29.77 EPS for the current year.

Cigna Group Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, March 19th. Stockholders of record on Thursday, March 5th will be issued a $1.56 dividend. This is a boost from Cigna Group’s previous quarterly dividend of $1.51. This represents a $6.24 dividend on an annualized basis and a dividend yield of 2.2%. The ex-dividend date of this dividend is Thursday, March 5th. Cigna Group’s dividend payout ratio is currently 27.23%.

Wall Street Analyst Weigh In

Several equities analysts recently weighed in on the stock. Robert W. Baird cut their price target on shares of Cigna Group from $372.00 to $315.00 and set an “outperform” rating on the stock in a report on Thursday, December 11th. Barclays cut their price objective on shares of Cigna Group from $305.00 to $303.00 and set an “overweight” rating on the stock in a research note on Friday, February 6th. Royal Bank Of Canada decreased their target price on shares of Cigna Group from $344.00 to $333.00 and set an “outperform” rating for the company in a research report on Friday, February 6th. Leerink Partners upped their price target on shares of Cigna Group from $270.00 to $297.00 and gave the company a “market perform” rating in a report on Friday, February 6th. Finally, Guggenheim reiterated a “buy” rating and set a $318.00 price objective on shares of Cigna Group in a research note on Monday, February 2nd. One analyst has rated the stock with a Strong Buy rating, sixteen have given a Buy rating and five have given a Hold rating to the company’s stock. Based on data from MarketBeat.com, Cigna Group currently has an average rating of “Moderate Buy” and a consensus target price of $330.42.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently added to or reduced their stakes in CI. Harbor Capital Advisors Inc. boosted its stake in shares of Cigna Group by 119.5% during the 3rd quarter. Harbor Capital Advisors Inc. now owns 90 shares of the health services provider’s stock worth $26,000 after acquiring an additional 49 shares in the last quarter. Wilkerson Advisory Group LLC acquired a new position in Cigna Group in the 4th quarter worth about $25,000. Beacon Financial Strategies CORP acquired a new position in Cigna Group in the 4th quarter worth about $28,000. Kemnay Advisory Services Inc. purchased a new position in Cigna Group during the fourth quarter worth approximately $29,000. Finally, Prosperity Bancshares Inc acquired a new stake in Cigna Group in the fourth quarter valued at approximately $29,000. Hedge funds and other institutional investors own 86.99% of the company’s stock.

Cigna Group News Roundup

Here are the key news stories impacting Cigna Group this week:

• Positive Sentiment: Cigna received an independent credit-rating vote of confidence: AM Best affirmed A (Excellent) FSR and “a+” long‑term issuer credit ratings for Cigna’s core life/health subsidiaries — supports financial stability and capital strength. AM Best affirms ratings
• Positive Sentiment: Cigna formally named President & COO Brian Evanko as its next CEO (effective July 1) and said Cordani will move to executive chair; management also reaffirmed 2026 financial outlook — the internal succession and guidance reaffirmation reduce execution/guidance risk versus an outsider pick. Cigna appoints Brian Evanko
• Neutral Sentiment: Cigna executives appeared at the TD Cowen healthcare conference this week — useful for incremental detail and Q&A but not a market-moving catalyst on its own. TD Cowen presentation notice
• Neutral Sentiment: Broader health-care weakness intraday pressured peers as the NYSE Health Care Index slipped — sector moves amplify company-specific headlines but are not unique to CI. Sector update
• Negative Sentiment: Market reaction to the CEO transition has been negative in the near term — investors appear concerned about leadership change and potential strategic shifts at Evernorth/PBM despite the internal appointment. Seeking Alpha on leadership transition
• Negative Sentiment: Piper Sandler (per recent coverage) issued a cautious note on near‑term outlook for CI, which can weigh on sentiment even if other analysts remain constructive. Piper Sandler pessimistic forecast
• Negative Sentiment: Insider selling was reported (director-level sale of ~1.7k shares) — small in isolation but often cited by traders as a short-term negative signal. Insider trade filing

Cigna Group Company Profile

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.